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Fractalkine (FKN) is a chemokine expressed constitutively by healthy neurons and
signals to microglia upon interaction with the FKN receptor, CX3CR1. Signaling between
FKN and CX3CR1 transduces inhibitory signals that ameliorate microglial activation
and proinflammatory cytokine release in neuroinflammatory conditions. The aim of this
study is to determine the mechanisms associated with microglial activation and vascular
leakage during diabetic retinopathy (DR) and under conditions of low-level endotoxemia,
common in diabetic patients. Utilizing the Ins2Akita strain (Akita), a mouse model of type 1
diabetes, our results show that leakage of the blood-protein fibrin(ogen) into the retina
occurs as a result of chronic (4 months) but not acute (1.5 months) hyperglycemia.
Conversely, inducing endotoxin-mediated systemic inflammation during acute diabetes
resulted in fibrinogen deposition in the retina, a phenotype that was exacerbated in
mice lacking CX3CR1 signaling. Systemic inflammation in Cx3cr1−/− mice led to robust
perivascular clustering of proliferating microglia in areas of fibrinogen extravasation,
and induced IL-1β expression in microglia and astrocytes. Lastly, we determined a
protective effect of modulating FKN/CX3CR1 signaling in the diabetic retina. We show
that intravitreal (iv) administration of recombinant FKN into diabetic FKN-KO mice,
reduced fibrinogen deposition and perivascular clustering of microglia in the retina during
systemic inflammation. These data suggest that dysregulated microglial activation via
loss of FKN/CX3CR1 signaling disrupts the vascular integrity in retina during systemic
inflammation.
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INTRODUCTION
Endotoxin levels—specifically bacterial lipopolysaccharide (LPS)—are found elevated in the
sera of diabetic patients contributing to disease incidence by upregulating IL-1β, IL-6, TNF-α,
C-reactive protein, plasminogen activator inhibitor type 1 (PAI-1) and fibrinogen (Cani
et al., 2007; Lassenius et al., 2011; Pussinen et al., 2011). Apart from being a risk factor
for infectious diseases and atherosclerosis (Shah and Hux, 2003), hyperglycemia also poses
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an increased risk of thrombotic events, evident by activation of
the coagulation system and inhibition of the fibrinolytic system
(Carr, 2001) in diabetic patients. Fibrinogen also known as
coagulation factor I, is abundant in the blood and functions in the
coagulation cascade creating polymers of fibrin. Fibrin clots form
in response to injuries to any part of the vascular system. In the
nervous tissue, fibrinogen is deposited as insoluble fibrin once
the blood-brain barrier is compromised (Davalos et al., 2012).
It has been shown that soluble fibrinogen in the bloodstream
is not proinflammatory, but fibrin formation as a result of
the activation of the coagulation cascade exposes fibrin cryptic
epitopes that lead to activation of innate immunity (Bardehle
et al., 2015). While a prominent role of fibrinogen exists in
mediating cellular activation and tissue damage in models of
neuroinflammation (Bardehle et al., 2015), less is known in
diabetic retinopathy (DR).
DR is a progressive retinal disease and leading cause
of blindness in diabetics. Growing evidence suggests
neuroinflammation plays an early role in mediating neuronal
and vascular pathology in DR (Zheng et al., 2007; Tang and
Kern, 2011; Li et al., 2012). Microglia, which are normally
engaged with neurons and taking part in synaptic maintenance
and clearance of cellular debris (Sierra et al., 2010; Paolicelli
et al., 2011), are now recognized as being more than just
intrinsic ‘‘bystanders’’, but immune cells with key roles in
injury and repair. In particular, during diabetes, inhibition
of microglial activation via administration of minocycline
attenuates both neuronal (Krady et al., 2005) and vascular
(Vincent and Mohr, 2007) degeneration in the retina by
dampening the proinflammatory response. Several studies
support the involvement of microglia-mediated inflammation in
DR pathogenesis. However, the impact of systemic inflammation
in microglia phenotype in a diabetic host is enigmatic. Therefore,
understanding the mechanisms that lead to retinal microglia
activation may provide unique therapeutic target to regulate
inflammatory reactions and ameliorate pathology during
retinopathy.
In the central nervous system (CNS), neurons constitutively
express Fractalkine (FKN), which binds to CX3CR1 on
microglia (Bazan et al., 1997; Imai et al., 1997; Combadiere
et al., 1998; Rossi et al., 1998; Jung et al., 2000; Cook
et al., 2001). Disruption of CX3CR1 signaling influences
microglial physiology in health and disease (Limatola and
Ransohoff, 2014). For example, microglia in CX3CR1-KO mice
are proinflammatory prone and contribute to exacerbated
neurotoxicity in several models of neurodegeneration (Cardona
et al., 2006) and also in DR (Cardona et al., 2015). Moreover,
it was recently reported that CX3CR1-deficiency accelerates
vascular degeneration following chronic diabetes (Beli et al.,
2016). These data suggest a relationship between CX3CR1 and
maintenance of the vascular integrity in the diabetic retina. Yet,
the contributions of dysregulated microglial activation on retinal
vascular damage during episodes of acute systemic inflammation
remain unknown.
Here, we sought to determine how CX3CR1 signaling
modulates microglial-vasculature responses during systemic
inflammation in the acute diabetic retina. We report that
following chronic (16 weeks), but not acute (6 weeks) diabetes,
fibrinogen leakage was evident in the retina irrespective of
the CX3CR1 genotype. In contrast, systemic inflammation
induced fibrinogen leakage in the acute diabetic retina, and
this effect was exacerbated in diabetic CX3CR1-KO mice
and correlated with perivascular clustering of activated
microglia. Interestingly, systemic LPS lead to robust retinal
vascular leakage in nondiabetic CX3CR1-KO but not
CX3CR1-HET mice. Lastly, we show that intravitreal (iv)
administration of recombinant FKN into diabetic FKN-KO
mice, reduced fibrinogen deposition and perivascular
clustering of microglia in the retina during systemic
inflammation.
MATERIALS AND METHODS
Mouse Models
C57BL/6, Cx3cr1gfp/gfp (CX3CR1-KO), and Insulin2Akita (Akita)
mice were purchased from The Jackson Laboratory and breeding
pairs of Cx3cl1−/− (FKN-KO) mice (Cook et al., 2001) were
obtained from Sergio Lira (Icahn School of Medicine at
Mount Sinai). All mice were in-bred and maintained at the
animal facilities at the University of Texas at San Antonio.
In this study, CX3CR1-KO mice were crossed with the
Akita type 1 diabetic strain to generate Akita CX3CR1-KO
(Akita-KO), Akita CX3CR1-HET (Cx3cr1+/gfp; Akita-HET) and
Akita CX3CR1-WT (Cx3cr1+/+; Akita-WT) mice as previously
described (Cardona et al., 2015). Aged-matched nondiabetic
and diabetic animals of their respective Cx3cr1 genotype
served as controls. Akita male mice become hyperglycemic
by 4 weeks old, and animals were maintained for 6 weeks
(10 weeks old) or 16 weeks (20 weeks old) thereafter to study
acute and chronic diabetes, respectively. Blood glucose was
measured using the Precision Xtra Kit via check puncture and
animals were deemed diabetic when blood glucose levels were
>400 mg/dL at time of experiment. This study was carried
out in accordance with National Institutes of Health guidelines
and approved by the UTSA Institutional Animal Care and Use
Committee.
Antibodies and Reagents
Rabbit anti-ionized calcium binding adaptor molecule-1
(IBA1; Wako; 1:4000), rabbit anti-fibrinogen (Clone: A0080;
Dako; 1:500), rabbit anti-proliferating cell nuclear antigen
(PCNA, Clone: C19; Abcam; 1:500), rat anti-nitric oxide
synthase (NOS2; Clone: CXNFT; Ebioscience: 1:500) rat anti-
pecam-1/CD31 (Clone: MEC 13.3; BD Pharmingen: 1:500),
Rat anti-glial fibrillary acidic protein (GFAP, Clone: 2.2B10,
Invitrogen; 1:4000), and biotinylated-isolectin B4 (IB4; 1:1000),
and avidin-biotin peroxidase complex were acquired from
Vector Labs. Species-specific secondary antibodies Cy3-goat
anti-rabbit, Cy5-donkey anti-rat, biotinylated-goat anti-rabbit;
biotinylated-goat anti-mouse; Cy3- and Cy5-streptavidin
conjugated antibodies were purchased from Jackson
Laboratories. Streptozotocin (STZ) and LPS from E. coli,
serotype 055:B5 were obtained from Sigma-Aldrich.
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Induction of Systemic Inflammation via
Lipopolysaccharide Injections
Acute endotoxemia (systemic inflammation) was established as
previously described (Cardona et al., 2006; Chen et al., 2012).
Briefly, acute diabetic and aged-matched nondiabetic male mice
were injected intraperitoneally (i.p.) with LPS (20 µg/100 µL
PBS/mouse/day; 1mg/kg of body weight) for four-consecutive
days, or mock injected with an equal volume of sterile
PBS. Aged-matched nondiabetic and diabetic animals of their
respective Cx3cr1 genotype served as controls for LPS-treated
animals.Mice were then sacrificed 4 h after the final LPS injection
for analysis as described below. In a selected experiment only
two doses of LPS were used to determine earlier effects of
systemically-induced inflammation on retinal fibrinogen leakage.
Immunofluorescence, Confocal
Microscopy and Image Analysis
Mice were transcardially perfused with cold saline buffer
followed by cold fixative (4% paraformaldehyde; PFA). For
retinal isolation, eyes were enucleated and postfixed in 4% PFA
overnight, retinas were then isolated free from sclera/retinal
pigmented epithelium and the resulting retinal flat mounts
were used for immunohistochemical staining as previously
described (Cardona et al., 2015). In brief, retinal tissues were
incubated for 4 h at 4◦C with 1% Triton-X 100 in 10% goat
serum to permeablize tissue and block nonspecific secondary
antibody staining, respectively. Next, primary antibodies were
incubated in the same buffer overnight at 4◦C followed
by rigorous washes, and then tissues were incubated with
species-specific secondary antibodies to visualize proteins of
interest. Confocal microscopy was done using a Zeiss LSM
510 microscope and 3D compositions of confocal images
were generated in Imaris software v7.2 (Bitplane). For each
different immunohistochemical stain the entire flat mount of
the retina was assessed, and a minimum of three images per
retina per mouse were obtained and further analyzed. To
quantify fibrinogen, microglial and astrocyte immunoreactivity
in confocal images, raw images were uploaded to ImageJ (NIH),
converted to 8-bit grayscale, and then a global automatic
threshold was applied to each image. Fibrinogen, microglia
and astrocytic signal per image were measured and expressed
as immunoreactivity percent or percent area of entire image.
For microglial cell counts, cells were manually counted in 40×
images. Data were normalized to X, Y and Z coordinates
(i.e., 210 µm × 210 µm × 15 µm) to account for changes
in confocal z-stack thickness and expressed as microglia
per mm3. To assess changes in microglial morphology, the
transformation index (TI) was determined in microglial cells
as previously described (Cardona et al., 2015). Briefly, 40×
confocal images were uploaded to ImageJ and the cellular
perimeter and area were obtained and used in the equation:
TI = Perimeter2/4∗Π∗Area. A circular shape has a TI equal
to 1 and when used to evaluate microglial morphology,
cells with ameboid shape have values closer to 1 whereas
ramified cells have much larger values. Lastly, the Imaris
Coloc tool was used to quantify the colocalization between two
fluorochromes in an image. The two channels of interest were
selected and an automatic threshold was performed on both
channels. Imaris Coloc volume statistics was used to present
data as the number of total colocalized voxels between two
channels.
Quantitative PCR
RNA was extracted from isolated retinas following the Trizol
method (Invitrogen), and quality control parameters assessed
as previously described (Jung et al., 2000; Cardona et al., 2015).
500 ng of total RNA was reverse-transcribed to cDNA using
the High-Capacity cDNA Reverse Transcription Kit (Applied
Biosystems). Samples were run in triplicate in 10 µL PCR
reactions containing 1X SYBR Green PCR Master Mix (Applied
Biosystems), 250 nM forward and reserve primers, and 20 ng
cDNA template. qPCR reactions were run in a 384-well plate
format using a 7900 HT Fast Real-Time PCR System (Applied
Biosystems). Results were analyzed by the comparative Ct
method as previously described (Cardona et al., 2015). Data
are expressed as 2-∆∆Ct for the experimental gene of interest
normalized to two separate housekeeping genes, Rn18s (18s) and
Actb (β-actin), and presented as the average fold change relative
to naive genotype-specific controls. The following primers
were used: Il1b (Accession number: NM_008361.3): Forward
(Fwd) 5′-GTGTGGATCCAAAGCAATAC-3′, Reverse (Rev) 5′-
GTCTGCTCATTCATGACAAG-3′; Nos2 (Accession number:
NM_010927.4): Fwd 5′-GGCAGCCTGTGAGACCTTTG-3′,
Rev 5′-TGCATTGGAAGTGAAGCGTTT-3′; 18s (Accession
number: NR_003278.3): Fwd 5′-CGGCTACCACATCCA
AGGAA-3′, Rev 5′-GTCGGAAATACCGCGGTC-3′; β-actin
(Accession number: NM_007393.3): Fwd 5′-CTCTGGCTCCT
AGCACCATGAAGA-3′, Rev 5′-GTAAAACGCAGCTCAGTA
ACAGTCCG-3′.
STZ-Induced Diabetes and Intravitreal
Administration of Recombinant Fractalkine
For FKN treatment experiments, FKN-KO were rendered
diabetic by administration of multiple-low doses of STZ as
previously described (Krady et al., 2005). In brief, mice received
daily i.p. injections of STZ (60 mg/kg/day) dissolved in citric
acid buffer (50 mM; pH 4.5) for five-consecutive days. Blood
glucose was monitored weekly after STZ injections, and mice
were sacrificed following 1 month of hyperglycemia reflected
by blood glucose levels >400 mg/dL. Citrate buffer injected
mice were used as controls (data not shown). Acute (2 day
LPS challenge) systemic inflammation was induced as described
above in diabetic FKN-KO mice. Following the second LPS
injection, mice received an iv injection of FKN or mock injection
with sterile PBS. In brief, mice were anesthetized with 5%
isoflurane in oxygen and injections were administered under
a dissecting microscope with a 31G beveled Nanofil needle
and syringe connected to a Micro 4TM Microsyringe Pump
Controller (World Precision Instruments). Prior to injections, a
drop of 0.5% proparacaine hydrochloride ophthalmic solution
(Akron) was applied to each eye as a topical anesthetic. One
eye received an iv injection of recombinant mouse CX3CL1/
FKN chemokine domain (Leu22-Lys105; R&D Systems) infused
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FIGURE 1 | Fibrinogen is detected in the retina at chronic stages of diabetes. Vascular leakage in naïve diabetic mice (Ins2Akita strain) at chronic (16 weeks)
and acute stages (6 weeks) of diabetes were assessed via detection of fibrinogen in the retina. (A,B) Confocal images revealed fibrinogen (white) immunoreactive
areas in retinal flat mounts of Akita CX3CR1-HET (Akita-HET) and Akita CX3CR1-KO (Akita-KO) mice at (A) chronic but not at (B) acute stages of hyperglycemia.
Moreover, fibrinogen colocalized to areas of activated microglia (CX3CR1-GFP; arrowhead) near blood vessels (CD31, red; arrows). Representative examples of
fibrinogen extravasation in (A1) Akita-HET and (A2) Akita-KO retinas are shown. (C) Fibrinogen immunoreactive area was quantified in confocal images and
expressed as mean ± SD (n = 4–5 mice per genotype) ns = not significant, nd = not detectable.
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at 200 nL/s for a total of 5 s (diluted in PBS; 30 ng/µL, 1 µL
injections). The contralateral eye received a mock injection with
an equal volume of sterile PBS. Following 24 h after the second
LPS and iv injections, mice were sacrificed and their retinas
analyzed.
Statistical Analysis
Statistical tests’ performed include two-tailed unpaired Student’s
t test when comparing two groups and one-way ANOVA
followed by Tukey’s post hoc test for multiple comparisons.
All analyses were conducted in GraphPad Prism v5.0 and a
P value<0.05 was considered statistically significant.
RESULTS
Fibrinogen Is Detected in Retinal Tissues
of Diabetic Mice at Chronic but Not Acute
Stages of Disease
We identified vascular leakage by staining for the blood-
protein fibrinogen in naïve Akita-HET and Akita-KO retinas
at chronic (16 weeks) diabetes. Fibrinogen staining colocalized
with morphologically-activated microglia (Figures 1A,C) in
areas closely associated with blood vessels. In some cases,
fibrinogen was found not only tightly associated with blood
vessels but also leaking into the parenchyma of the retina
(Figure 1A1,2). Fibrinogen deposition in retinal blood vessels
of Akita mice was not evident in acute (6 weeks) stages
of diabetes regardless of CX3CR1 genotype (Figures 1B,C;
Table 1). However, perivascular accumulation of fibrinogen
during chronic stages (16 weeks) of diabetes was apparent,
although microglial infiltration was minimal. These data suggest
that retinal blood vessels exposed to chronic hyperglycemia and
neuroinflammation associated with DR (Roy et al., 2017) is
required for larger plasma proteins, such as fibrinogen, to leak
into the diabetic retina.
Systemic Inflammation Accelerates
Fibrinogen Leakage in the Acute Diabetic
Retina and CX3CR1 Controlled the Extent
of Perivascular Clustering of Microglia
Increase levels of plasma LPS, a major component of
gram negative bacteria cell walls, the high prevalence of
recurrent infections, and the associated increase of circulating
TABLE 1 | Fibrinogen leakage in retinas of naïve (non-lipopolysaccharide
(LPS) treated) animals.
Genotype Duration of Fibrinogen Perivascular
diabetes detected in clustering
retina (mice) microglia
CX3CR1-HET – 0/6 No
Akita-HET 6 weeks 0/4 No
Akita-HET 16 weeks 5/5 Limited
CX3CR1-KO – 0/6 No
Akita-KO 6 weeks 0/4 No
Akita-KO 16 weeks 4/5 Limited
pro-inflammatory cytokines in hyperglycemic patients (Cani
et al., 2007; Lassenius et al., 2011; Pussinen et al., 2011) pose
an important and unexplored intersection between systemic
inflammation and DR progression. Immunohistochemical
analyses revealed that fibrinogen was not detected in nondiabetic
CX3CR1-HET mice challenged with 4 day LPS (Figures 2A,B;
Table 2). Whereas, fibrinogen deposition was evident in close
association to retinal blood vessels in nondiabetic CX3CR1-KO
mice and colocalized to areas of perivascular clustering of
microglia (Figure 2A). Furthermore, immunostaining showed
perivascular IB4+microglia/monocytes around aberrant vascular
staining (Figure 2A); consistent with literature showing that
microglia/myeloid cells upregulate IB4 upon activation (Chen
et al., 2010). Interestingly, in acute diabetic mice (6 weeks),
LPS had an augmented effect and resulted in vascular leakage
evident with fibrinogen accumulation in the retinas of diabetic
Akita mice, mainly in the Akita-KO retinas (Figures 2A,B).
More specifically, fibrinogen staining in the retina was detected
in 50% of LPS-treated Akita-HET mice, whereas fibrinogen
deposition was present in 88% of LPS-treated Akita-KO animals
(Table 2). Importantly, areas of fibrinogen immunoreactivity
only correlated with microglial activation (immunoreactivity) in
LPS-treated CX3CR1-KO and Akita-KO retinas (Figures 2C–E).
Together, these experiments show that elevated systemic
inflammation can accelerate breakdown of the blood-retinal
barrier (BRB) as evidenced by fibrinogen extravasation.
Additionally, these data suggest that CX3CR1 signaling may
play a role in maintaining the BRB during insult, perhaps
indirectly by modulating protective microglial responses in both
nondiabetic and diabetic mice.
Early Fibrinogen Deposition Correlates to
the Microglial Clustering Phenotype
Observed in CX3CR1-KO Mice
We next assessed retinas for fibrinogen leakage at an earlier
time point during systemic inflammation, 2 days after LPS
administration. Since the 4 day LPS data shows a dramatic
difference between the CX3CR1-KO and control groups,
this experiment was designed to make sure that mice that
express CX3CR1 do not show blood vessel abnormalities early
after one or two doses of LPS that may have resolved by the
fourth dose. As proof of concept we only performed these
experiments in nondiabetic animals since fibrinogen leakage and
perivascular clustering of microglia was evident in nondiabetic
4-day LPS-treated CX3CR1-KO mice. The pattern of the
vascular staining in 2 days LPS-treated CX3CR1-KO mice was
discontinuous and aggregated clumps of the endothelium were
observed around perivascular microglial clusters (Figure 3A;
white arrowheads). Furthermore, as observed in the 4-day
challenge, 2 day LPS-treated CX3CR1-KO mice, showed
increase perivascular deposition of fibrinogen (Figures 3B,C;
yellow arrowhead), which coincided with increase microglial
activation/immunoreactivity (Figure 3D). Conversely, minimal
fibrinogen staining was detected histochemically in retinas of
2 day LPS-treated CX3CR1-HET mice (Figures 3B,C). The
extent of morphological microglial activation (Figures 3A,B)
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FIGURE 2 | Endotoxin-induced systemic inflammation triggers fibrinogen accumulation in the diabetic retina and correlates with perivascular
microglia clustering in CX3CR1-KO mice. (A) Retinal vascular leakage after systemic inflammation (4 days lipopolysaccharide (LPS)) was assessed by
immunostaining for the blood-protein fibrinogen. Fibrinogen deposition (white) around retinal blood vessels (CD31; red) colocalized to microglial lesions
(CX3CR1-GFP, green), except in nondiabetic CX3CR1-HET mice (Scale bars: 40 µm). Far right panels show evidence of isolectin B4+ (isolectin b4; IB4, red) cells
around disrupted vascular staining in CX3CR1-KO mice (Scale bars: 50 µm). (B) Fibrinogen and (C) microglial CX3CR1-GFP immunoreactivity were quantified per
confocal image and data presented as mean ± SEM (n = 4–7 mice per group). ∗P < 0.05 by ANOVA with Tukey’s HSD (See Table 2 for incidence). (D) Scatter plot
analysis of fibrinogen % Area as a function of microglia % Area from data in panels (B,C). (E) Representative high-power confocal image of LPS-treated Akita-KO
retina immunostained for fibrinogen (white), microglia (green) and vasculature (CD31, red). Scale bars: 15 µm. ∗∗P < 0.01.
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TABLE 2 | Fibrinogen leakage in retinas of LPS-treated animals.
Genotype Duration of diabetes Treatment Fibrinogen detected in retina (mice) Perivascular clustering microglia
CX3CR1-HET – 2 day LPS 0/3 No
CX3CR1-HET – 4 day LPS 0/9 No
Akita-HET 6 weeks 4 day LPS 4/8 Limited
CX3CR1-KO – 2 day LPS 3/3 Yes
CX3CR1-KO – 4 day LPS 5/8 Yes
Akita-KO 6 weeks 4 day LPS 7/8 Yes
FKN-KO – 2 day LPS 3/4 Yes
FKN-KO – 4 day LPS 4/4 Yes
FKN-KO 4 weeks 2 day LPS + PBS (iv)∗ 4/4# Yes
FKN-KO 4 weeks 2 day LPS + FKN (iv)∗ 4/4# Yes
Data are presented as number/proportion of mice that score positive for fibrinogen deposition in the retina and in which the staining was closely associated to blood
vessels, or visualized in the parenchyma of the neural retina.∗ Intravitreal (iv) injection of either sterile PBS or recombinant fractalkine (FKN). #A significant reduction in
fibrinogen signal was observed following FKN treatment relative to PBS and data are shown in Figures 6H,I.
was supported by assessment of TI, which accounts for
cellular perimeter and area. The results confirmed that
2 day LPS challenge significantly altered the morphology of
microglia in CX3CR1-KO relative to CX3CR1-HET mice
(Figure 3E). CX3CR1-HET microglia appeared to have smaller
cell bodies, long-ramified processes (Figures 3B,E), and a
uniform distribution throughout the retina based on CX3CR1-
GFP: CD31 colocalization analysis (Figure 3F). In contrast,
CX3CR1-KO microglia displayed classic ameboid morphology
evident of morphological activation and microglia were
significantly more associated with the vasculature (Figure 3F).
These data bolster the rationale that CX3CR1 controls the
normal physiology of microglial during insult and that in
absence of CX3CR1, low levels (1 mg LPS per kg animal) of
acute (2 days) systemic inflammation is sufficient to make retinal
blood vessels leaky.
Clustering Phenotype of
Morphologically-Activated
CX3CR1-Deficient Microglia Correlates
with Increased Numbers of Proliferating
Cells in the Retina during Systemic
Inflammation
We sought to investigate the role of CX3CR1 deficiency in
microglia activation in response to systemic inflammation
under physiological and diabetic states. Endotoxin-induced
inflammation (4 day challenge) did not induce significant
changes to the distribution of retinal microglia in CX3CR1-HET
mice (Figure 4A). In contrast, 4 day LPS-treated CX3CR1-KO
mice displayed robust microglial lesions or clusters around
retinal blood vessels (Figure 4A, bottom left, white arrowhead).
This unique clustering phenotype of microglia was observed
primarily in the peripheral retina distal to the optic nerve
head and was limited to one or two clusters per retina in
nondiabetic CX3CR1-KOmice, whereas no microglial clustering
was apparent in nondiabetic CX3CR1 wild type or heterozygous
mice. In 4 day LPS-treated Akita-HET mice (Figure 4A, top
right), microglial cells were grouped near blood vessels mostly
at the optic nerve head (Figure 4A, top right; white arrowhead).
However, in Akita-KO mice, systemic LPS had an exacerbated
effect on microglial activation in the diabetic retina, represented
by global perivascular clustering (Figure 4A, bottom right; white
arrowheads). This phenotype was intensified in comparison
to nondiabetic CX3CR1-KO mice and perivascular lesions of
microglia were observed throughout the entire tissue involving
multiple aggregations (Figure 4A, bottom right).
Images from naïve nondiabetic retinal tissues revealed classic
ramified nonreactive microglial cells in both CX3CR1-HET and
CX3CR1-KO mice (Figure 4B, red arrowheads). Furthermore,
in agreement with our previous report (Cardona et al., 2015),
acute diabetes was sufficient to activate microglia in naïve
Akita-HET and Akita-KO retina—which exhibit morphological
characteristics of reactive microglia including truncated cellular
processes and ameboid morphology that is consistent with
descriptions of a reactive/activated phenotype (Figure 4B,
yellow arrowheads). Systemic inflammation (4 days) exacerbated
the extent of microglial activation in both the nondiabetic
(Figure 4A) and Akita-HET and Akita-KO retinas (Figure 4B,
white arrowheads). The use of the TI to assess changes in
microglial morphology confirmed that systemic LPS had a
significant effect on microglial activation in both nondiabetic
and diabetic groups relative to naïve nondiabetic controls
(Figure 4C). However, the response to systemic inflammation
was more prominent in CX3CR1-deficient mice than in
CX3CR1-sufficient groups (Figure 4C). Interestingly, diabetes
alone promoted a significant effect on microglial morphology as
revealed by the data comparing CX3CR1-HET and Akita-HET
mice (Figure 4C). Furthermore, image analysis showed that 4 day
LPS treatment increased the number of microglial cell numbers
in all groups, but similarly to the TI quantification, the change
was more evident in CX3CR1-KO mice (Figure 4D).
To distinguish if these microglia foci were formed in response
to cellular mobilization or due to microglial proliferation,
retinal tissues were stained with the mitotic marker PCNA.
This experiment was limited to nondiabetic animals since
the clustering phenotype of microglia was observed in both
nondiabetic and diabetic CX3CR1-KO mice. Following 4 days of
LPS-treatment, retinal CX3CR1-KO microglia showed increased
immunoreactivity for PCNA, which colocalized with the specific
CX3CR1-GFP reporter protein and the microglial marker IBA1
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FIGURE 3 | Fibrinogen deposition and microglial activation is induced in Cx3cr1−/− mice early after endotoxin-induced systemic inflammation.
Nondiabetic mice were challenged with LPS for two consecutive days at which (A) microglial activation (CX3CR1GFP) and cell clustering near vessels (IB4; red) was
evident in CX3CR1-KO but not in CX3CR1-HET mice. Microglial clustering and abnormal vascular staining (white arrowheads) were associated with (B) fibrinogen
(white) immunoreactivity in retinal blood vessels (CD31, red) of CX3CR1-KO mice only (yellow arrowhead). (C) Fibrinogen and (D) microglia immunoreactivity were
compared among groups. (E) Transformation index (TI) was quantified per image and used to assess changes in microglial morphology in response to systemic LPS
(20–30 individual microglial cells quantified per mouse; n = 3). (F) Microglia (CX3CR1-GFP) interaction with CD31+ blood vessels was assessed by measuring the
colocalization (voxels) of GFP and CD31 fluorescence. Data in (C–F) are expressed as mean ± SD, n = 3. ∗P < 0.05, ∗∗∗P < 0.001 by Student’s t-test. Scale bars:
50 µm.
(Figure 4E). CX3CR1-KO mice displayed a significant increase
in the number of PCNA+ retinal microglia when compared
to CX3CR1-HET mice (Figure 4F). Additionally, CX3CR1-KO
microglia increased their expression of IBA1 by 2.2-fold in
response to systemic LPS (Figure 4G). These data suggest that
retinal microglia are highly sensitive to systemic inflammation,
and the rapid response involves intense microglial reactivity and
proliferation at targeted vascular sites where fibrinogen leakage
was evident.
In Response to Systemic Inflammation
CX3CR1 Deficient Microglia Exhibit an
Activated Phenotype Associated With
Upregulation of the Proinflammatory
Mediators IL-1β and iNOS
FKN signaling controls the proinflammatory phenotype of
microglia in the brain during systemic inflammation and in
animal models of amyotrophic lateral sclerosis (ALS), and
Parkinson’s disease (PD; Cardona et al., 2006). Furthermore, we
recently reported that absence of CX3CR1 induces microglial-
mediated IL-1β and neurotoxicity in the Akita model of
DR (Cardona et al., 2015). Yet, as to what extent systemic
inflammation influences the phenotype of retinal microglia
remains elusive. Therefore, we stained for the proinflammatory
markers IL-1β and inducible nitric oxide synthase (iNOS or
NOS2, the enzyme required for nitric oxide synthesis), which
are both recognized as key mediators that contribute to the
pathogenesis of rodent and human DR (Tang and Kern, 2011).
Nondiabetic 4 day LPS-treated CX3CR1-KO mice showed an
increase expression of IL-1β in microglia (Figure 5A, yellow
arrowheads), whereas minimal levels of IL-1β were detected in
4 day LPS-treated CX3CR1-HET mice (Figure 5A). Increased
expression of IL-1β was also noted in cellular processes of
GFAP+ astrocytes (Figures 5A,A1, yellow arrows). Similarly,
most of the retinal microglia in the LPS-treated CX3CR1-KO
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FIGURE 4 | Systemic inflammation promotes microgliosis and perivascular clustering of microglia in the retina of CX3CR1-deficient mice.
(A) Confocal images of microglia (CX3CR1-GFP, green) in retinal flat mounts following 4 d LPS challenge in nondiabetic CX3CR1-HET and CX3CR1–KO mice and
diabetic Akita-HET and Akita-KO tissues. Robust microglial clustering near retinal blood vessels (white arrowheads) was observed in nondiabetic LPS-treated
CX3CR1-KO but not in LPS-treated CX3CR1-HET mice. Perivascular clustering of microglia was exacerbated in LPS-treated Akita-KO compared to Akita-HET mice.
(Continued)
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FIGURE 4 | Continued
(B) Images of higher magnification illustrating global microglia morphological
activation in LPS-treated diabetic retinas (white arrowheads) in comparison to
both naïve (PBS) nondiabetic (red arrowheads) and naïve diabetic retinal
microglia (yellow arrowheads). (C) The TI was quantified in individual microglial
cells to assess changes in morphology (n = 6 mice per group; 20–30 microglia
quantified per mouse). Values closer to one represent cells with more circular
and ameboid shape. (D) Microglial cell numbers were quantified in retinal
tissues and normalized to the volume of each z-stack (n = 6–8 mice per
group; three images per retina per mouse). (E) Retinal tissues of 4 day
LPS-challenged nondiabetic CX3CR1-HET and CX3CR1-KO mice were
stained with antibodies against proliferation cell nuclear antigen (PCNA, white)
and ionized calcium binding adaptor molecule-1 (IBA1; red), which colocalized
to CX3CR1-GFP reporter (green). Scale bars: 25 µm in (B,E). (F) Image
quantification of PCNA+ microglia (GFP+ and IBA1+) and (G)
IBA1 immunoreactivity in LPS- or PBS-treated (naïve) mice (n = 3 mice per
group; three images per mouse). Data are presented as mean ± SD in (C,F,G)
and SEM in (D) ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 by ANOVA followed by
Tukey’s HSD test.
retina colocalized to areas of iNOS immunoreactivity, and only a
few NOS2+ activated microglia were observed in CX3CR1-HET
tissues (Figure 5B, blue arrowheads). Indeed, qPCR analyses
revealed that systemic inflammation induced a 2.6-fold increase
of Il1b mRNA in the retinas of LPS-treated nondiabetic
CX3CR1-KO compared to CX3CR1-WT mice (Figure 5C).
Similarly, a 3.7-fold increase in Il1b and a 2-fold increase in
Nos2 relative expression was observed in LPS-treated Akita-KO
compared to LPS-treated Akita-WT mice (Figures 5C,D).
No significant differences were observed in the nondiabetic
groups between Nos2 expression, although the values were
elevated relative to their respective naïve groups. Collectively,
these data further bolster the concept that the absence of
FKN signaling confers a proinflammatory and potentially toxic
microglial phenotype that can perpetuate neuroinflammatory
tissue damage.
Fractalkine Dampens Retinal Microglia
Activation, Perivascular Clustering and
Fibrinogen Deposition in the Diabetic
Retina Following Systemic Inflammation
We next explored the scenario of utilizing recombinant FKN
to reconstitute the retinal environment of FKN-KO mice in
an attempt to attenuate microglial responses during systemic
inflammation. For this, we first evaluated the phenotype of
nondiabetic FKN-KO mice in response to 4 day LPS-induced
inflammation, and found that the robust microglial activation
and clustering phenotype observed in nondiabetic CX3CR1-KO
and Akita-KO mice was replicated in the ligand deficient mice
(Figures 6A–D). To evaluate the consequences of acute exposure
of soluble FKN to a FKN void environment on regulating the
observed microglial activation/clustering phenotype and extent
of fibrinogen leakage in the diabetic retina, we established
diabetes in FKN-KO mice via STZ administration. Diabetes was
sustained in animals for 1 month to allow metabolic changes
to normalize and to study acute hyperglycemia as similarly
done in Akita mice. To limit the toxicity of STZ-induced
diabetes in combination with systemic inflammation we only
performed a 2 day LPS protocol in diabetic FKN-KO mice
since we observed a similar trend (data not shown; Table 2)
of increased microglial cellularity and fibrinogen leakage as
observed in 4 day LPS-treated CX3CR1-KO mice (Figure 3).
Intravitreal delivery of antibodies and steroids are currently
approvedmethods for DR treatment, and thus we took advantage
of that route of delivery to reconstitute the vitreous cavity
for 24 h of diabetic FKN-KO mice following 2 day systemic
inflammation in an attempt to rescue the observed phenotype.
Mice that received sterile PBS (left eyes of mice serviced
as vehicle controls) showed intense perivascular clustering of
microglia and astrogliosis, in the context of GFAP staining,
around blood vessels (Figure 6E). Whereas mice treated with
recombinant FKN showed a reduction in perivascular microglia
(Figure 6F) and GFAP staining (Figure 6G) in the retina.
Indeed, robust fibrinogen staining was evident around disrupted
vasculature in eyes that received PBS (Figure 6H, yellow arrows).
In contrast a significant (P = 0.045) reduction in fibrinogen
deposition was observed in FKN-treated eyes. Together, these
data suggest that the soluble form of FKN can attenuate
microglial activation during insult, and may also dampen
inflammation providing an environment more conducive for
repair.
DISCUSSION
It has been shown that fibrinogen leaks into the diabetic retina
of patients when the BRB is compromised (Murata et al.,
1992). In this study, we show that fibrinogen/fibrin deposition
in the retina occurs as a result of chronic (16 weeks) but
not acute (6 weeks) stages of diabetes, and is associated with
activated microglia (Figure 1). Other investigators have shown
that retinal vessels can become leaky early during diabetes
in the context of detection of serum albumin within the
retina. However, fibrinogen is a large glycoprotein with a
molecular weight of 340-kDA relative to 65-kDA of albumin,
highlighting the extent of barrier damage. Hyperglycemia
increases the plasma levels of fibrinogen in patients (Murata
et al., 1992; Schmidt et al., 1999; Duncan et al., 2003),
due to inhibition of fibrinolysis, the enzymatic breakdown of
fibrin (ogen) (Carr, 2001). Blood vessels may become more
permeable/leaky as a consequence of early acute inflammation
to promote extravasation of larger plasma proteins as in human
DR (Asakawa et al., 2000) and thus accelerate inflammatory-
mediated damage to the retina. This type of fibrinogen
deposition was recapitulated in our mouse model. Although
diabetes is a procoagulant prone disease, and endotoxemia
has been shown to inhibit fibrinolysis in diabetic patients
(Stegenga et al., 2008), knowledge regarding endotoxemia during
early DR pathogenesis remains unknown. Interestingly, we
found that during acute diabetes, an episode of endotoxin-
induced systemic inflammation lead to early damage to the
BRB and increased fibrinogen extravasation into the retina
(Figure 2). This effect was significantly exacerbated in the
absence of FKN signaling and fibrinogen deposition correlated
with perivascular clustering of activated microglia in the diabetic
retina (Figures 2–4).
Frontiers in Cellular Neuroscience | www.frontiersin.org 10 January 2017 | Volume 10 | Article 303
Mendiola et al. Fractalkine and Fibrinogen during DR
FIGURE 5 | Enhanced microglia activation in CX3CR1-KO retinas based on upregulation of IL-1β and NOS2. (A,B) Confocal images of retinal flat mounts
from nondiabetic 4 day LPS-treated CX3CR1-HET and CX3CR1-KO mice immunostained for (A) IL-1β (white), (A1) glial fibrillary acidic protein (GFAP; red) and (B)
inducible nitric oxide synthase (iNOS or NOS2, red). Microglia visualized by virtue of the CX3CR1-GFP reporter are shown in green in (A) and pseudo-colored to
white in (B). IL-1β staining colocalized to both microglia (A,A1, yellow arrowheads), and astrocytes (A,A1; GFAP staining (red), yellow arrows) around blood vessels.
iNOS+ activated microglia were abundant in retinas of LPS-treated CX3CR1-KO mice relative to CX3CR1-HET mice (B, blue arrowheads). Scale bars: 25 µm. (C,D)
qRT-PCR analyses of (C) Il1b and (D) Nos2 transcripts in whole retinal extracts are presented as mean fold change (from ddCT) over respective naïve
genotype ± SD for n = 4 mice per group, ∗P < 0.05, ∗∗P < 0.01, ns = not significant, by ANOVA with Tukey’s HSD.
During health, FKN/CX3CR1 signaling contributes to
prenatal and postnatal brain development (Paolicelli et al.,
2011; Hoshiko et al., 2012). Here, our results highlight the
importance of the FKN/CX3CR1 signaling axis in retinal
microglia function during DR and endotoxemia. Intriguingly,
systemic LPS in nondiabetic animals resulted in fibrinogen
leakage and robust microglial proliferation around areas of
fibrinogen staining in CX3CR1-KO but not CX3CR1-HET mice.
Histochemical analyses revealed that systemic LPS upregulated
IL-1β levels in perivascular microglia and astrocytes (Figure 5).
Interestingly, IL-1β is known to promote vascular leakage and
angiogenesis. Whereas, blocking IL-1β improved endothelial
dysfunction in diabetic models (Vallejo et al., 2014) and
prevented choroidal neovascularization in models of laser-
induced retinal degeneration (Lavalette et al., 2011). Indeed,
both microglia (Halle et al., 2008) and astrocytes (Minkiewicz
et al., 2013) have the machinery to release bioactive IL-1β levels.
Also, activated microglia release ATP (Pascual et al., 2012)
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FIGURE 6 | Intravitreal (iv) treatment with recombinant fractalkine (FKN) dampens perivascular microglial clustering and fibrinogen deposition in
diabetic mice after systemic inflammation. (A,B) Confocal images of retinas from nondiabetic FKN-KO mice stained with (A) IBA1 (microglia, green) or along
with (B) IB4 (blood vessels, red) following systemic inflammation (4 day LPS) and compared to naïve (mock injected with PBS) FKN-KO mice. White arrowheads
indicate perivascular clusters of microglia in response to systemic LPS. Scale bars: (A) 100 µm, (B) 50 µm. (C) Microglial cells and (D) TIs indexes were quantified
per image and data are presented as mean ± SD (n = 6; three images per mouse). (E–I) During 1 month of streptozotocin (STZ)-induced diabetes, acute systemic
inflammation (2 day LPS) was induced in FKN-KO mice. Immediately following the second LPS injection, mice received an iv delivery of recombinant FKN (30 ng in
1 µL PBS) and an equal volume of PBS in the contralateral eye and retinal tissue were harvested and analyzed 24 h later. (E) Representative images of retinal tissue
stained with IBA1 (microglia, green), CD31 (blood vessels, red) and GFAP (astrocytes, white) from diabetic FKN-KO mice treated with LPS and then either FKN or
PBS administered into in the vitreous cavity. The higher magnification panels highlight less perivascular clustering of microglia and reduced GFAP staining around
vessels in FKN treated tissues relative to controls (blood vessels outlined in either yellow lines or yellow arrows). Scale bars: 150 µm; higher magnification images are
30 µm. (F,G) Image quantification of (F) microglial and (G) GFAP immunoreactivity presents data as mean ± SD (n = 5; three images per mouse). (H,I) Confocal
images of retinal tissue stained with fibrinogen (white), CD31 (red), Hoechst stain (nuclei, blue) and (I) fibrinogen immunoreactivity per image were quantified and
expressed as percent area (n = 4, 2–3 images per mouse). Scale bars: 50 µm. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 by Student’s t-test.
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increasing extracellular danger signals that in an autocrine
and paracrine fashion may sustain microglial and astrocytic
release of IL-1β in the retina. Along those lines, CNS endothelial
cells express interleukin-1 receptor type 1 (IL-1R1) and have
been recently shown to respond to myeloid derived IL-1β and
contribute to neuroinflammation and autoimmune disease
(Lévesque et al., 2016). We speculate based on our results
that CX3CR1 contributes to maintaining the integrity of the
BRB during endotoxemia, perhaps indirectly by repressing
proinflammatory cytokines released from activated microglia
and astrocytes that can act on endothelial cells. Lastly, interaction
of FKN with fibrinogen directly at the vascular site may dampen
the influx of fibrinogen and hence hinderingmicroglia activation.
These latter hypotheses need further investigation. However,
the results provide observations that are consistent with the
spatial correlation of fibrinogen deposition and microglia
activation as reported in animal models of multiple sclerosis
(MS; Akassoglou et al., 2004; Adams et al., 2007; Davalos et al.,
2012) and Alzheimer’s disease (AD; Paul et al., 2007).
This study suggests a novel working model for the pathology
of DR with direct implications in microglial lesion formation,
disruption of vascular integrity, and perivascular fibrinogen
deposition in the diabetic retina. Fibrinogen is a plasma protein
that under normal homeostatic conditions does not reach the
brain, spinal cord or retinal tissues. However, leaky vessels
allow the extravasation of fibrinogen and exposure to neuronal
tissues where is deposited as insoluble fibrin (Davalos et al.,
2012). The inflammatory effects of fibrinogen are associated with
neurological diseases such as MS (Adams et al., 2007; Davalos
et al., 2012; Ryu et al., 2015), stroke (Cheung et al., 2008)
and AD (Flemming, 2014). Importantly, fibrinogen has been
linked to microglial activation in vitro and in vivo, and a causal
relationship between fibrinogen deposition and perivascular
clustering of microglia in the CNS in experimental models of
neuroinflammation has been described (Davalos et al., 2012;
Ryu et al., 2015). Indeed, depletion of fibrinogen or inhibition
of fibrin formation by anti-coagulants suppressed microglial
activation and disease pathogenesis in animal models of MS
(Adams et al., 2007; Han et al., 2008; Davalos et al., 2012).
This report here only highlights the relevance of fibrinogen as
a marker of vascular leakage and association with microglial
activation. Future studies will explore the potential role of
fibrinogen leakage into the retina. Moreover, characterization
of the type of vascular degeneration in response to systemic
inflammation, such as quantification of acellular, nonperfused
capillaries and pericyte dropout would help elucidate the
extent of vasoregression and the potential occurrence of
neovascularization.
Intravitreal injection injection has become the most accepted
ophthalmic procedure in the treatment of DR, and in particular,
for the administration of anti-VEGF agents in neovascular
age-related macular degeneration, and other various vascular
disorders (McCannel, 2011). These therapeutic alternatives are
mostly implemented at chronic stages of disease (Cheung et al.,
2010) and efforts to treat early DR are hindered by the lack of
mechanistic insights on disease initiation and progression. Our
study reveals a novel outcome of soluble FKN in the treatment
of DR. Introducing soluble FKN into the retinas of diabetic
(STZ) FKN-KO mice was sufficient to attenuate microglial
perivascular clustering and reduce fibrinogen deposition during
acute endotoxin-induced inflammation (Figure 6). Accordingly,
it has been demonstrated that increasing FKN/CX3CR1 signaling
via iv delivery of FKN, dampens microglial activation and
photoreceptor degeneration in a model of retinal disease (Zabel
et al., 2016). Therefore, future studies addressing the effect of
FKN administration in visual acuity will be valuable to validate
its use to ameliorate retinal damage during retinopathy. As
discussed earlier, potential interactions between microglia and
astrocytes will be valuable to dissect, since astrogliosis, in the
context of GFAP staining (which notably also stains Müller cells
in the retina), was also diminished near blood vessels in FKN
treated eyes (Figures 6E,G). Astrocytes along with Müller cells
constitute a major glial cell population in the retina and provide
neuronal, vasculature and vision support. Evidence supports
that astrocytes and Müller cells provide protective functions
during diabetes, however, these cells have the capacity to
release proinflammatory mediators and contribute to oxidative
stress during DR (Xu et al., 2014). Thus, the concomitant
regulation of reducing the proinflammatory release of cytokines
in microglia and macroglia may yield promising therapeutics
for DR treatment. Given the decrease of FKN in retinal tissues
of Akita-WT mice (Cardona et al., 2015), the potential benefits
of FKN administration presents a promising scenario for DR
and other retinal diseases. Furthermore, the research presented
here poses important clinical relevance for humans carrying the
polymorphic variant CX3CR1I249/M280 (CX3CR1M280) estimated
in about 20% of the population. These changes in human
CX3CR1 decrease FKN affinity (McDermott et al., 2003) and
several studies support a role for CX3CR1M280 in susceptibility to
age-related macular degeneration (Tuo et al., 2004; Chan et al.,
2005; Brión et al., 2011; Schaumberg et al., 2014). Together,
our data suggest a pivotal role for FKN/CX3CR1 signaling
in governing microglial responses during insult, and thus
modulating CX3CR1 signaling may be relevant alternative
approaches to mitigate tissue pathology in the diabetic retina.
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